GlobeNewswire by notified

Interim Financial Report for the Period 1 January – 30 September 2023

Share


Company Announcement No. 9 – 2023
to Nasdaq Copenhagen


26 October 2023

Interim financial report for the first nine months of 2023

Consolidated revenue for the third quarter of 2023 was DKK 1,229.3 million, which is DKK 99.3 million, or 7.5%, less than for the third quarter of 2022. Consolidated revenue for the first nine months of 2023 was DKK 3,899.6 million, which is DKK 0.9 million more than for the same period last year. The gross profit margin for the first three quarters decreased by 0.4 percentage point compared with the same period of 2022 driven by one-time effects related to supplier-driven price increases in 2022.  In the third quarter, there was one less selling day relative to the prior year period. The day-to-day sales index saw a sharp decline in September causing third quarter results to be lower than expected.

Operating profit (EBIT) for the third quarter of 2023 was DKK 72.1 million, corresponding to a profit margin of 5.9%, against DKK 93.9 million and 7.1% for the third quarter of 2022. Operating profit (EBIT) for the first nine months of 2023 was DKK 226.4 million, corresponding to a profit margin of 5.8%, against DKK 271.1 million and 7.0% for the first three quarters of 2022.

Profit before tax (EBT) for the third quarter of 2023 was DKK 63.3 million, which is DKK 28.3 million less than in the third quarter of last year. Profit before tax for the first nine months of 2023 amounted to DKK 203.9 million, corresponding to a decrease of DKK 64.6 million. 

The Group’s total assets as at 30 September 2023 amounted to DKK 3,268.0 million, which is DKK 31.9 million less than at the same time in 2022.

The Group’s equity as at 30 September 2023 was DKK 1,423.6 million, which is DKK 100.7 million more than at the same time in 2022. The solvency ratio was 43.6% against 40.1% at 30 September 2022. The solvency ratio is above the ambition of at least 40%.

Cash flow from operating activities totalled DKK 209.1 million for the third quarter of 2023 and DKK 49.9 million for the first three quarters of 2023, which is DKK 221.4 million and DKK 98.6 million more than in the same periods last year. The development is driven by changes in working capital where inventory levels were reduced. Investments for the third quarter of 2023 totalled DKK 24.2 million and DKK 93.0 million for the first nine months of 2023, compared with DKK 21.0 million and DKK 268.6 million in 2022.

The Group’s financial leverage, measured as the ratio between the net interest-bearing debt and the EBITDA of the last 12 months, was 1.7 as at 30 September 2023, against 1.6 at the same time last year and 1.1 as at 31 December 2022. The financial leverage decreased from 2.0 as at 30 June 2023 and is expected to decrease further in the remainder of 2023. 

Expectations for the year

As previously stated in Company Announcement No. 8/2023 dated 12 October 2023, third quarter revenue and earnings were lower than expected with negative sales indexes in September. Based on projections from current trading, expectations for the rest of the year have been adjusted downwards.

Revenue
Revenue for 2023 is expected to be in the region of DKK 5,150-5,300 million. Previous expectations were in the region of DKK 5,350-5,500 million. Revenue for 2022 was DKK 5,375.0 million.

EBITDA
EBITDA for 2023 is expected to be in the range of DKK 400-430 million, corresponding to an EBITDA margin of 7.5%-8.3%. Previous EBITDA expectations were in the range of DKK 435-465. EBITDA for 2022 was DKK 491.6 million.

EBT
EBT is expected to be in the region of DKK 260-290 million, corresponding to an EBT margin of 4.9%-5.6%. Previous EBT expectations were in the region of DKK 300-330 million. EBT for 2022 was DKK 377.4 million.

A webcast will be held on 26 October 2023, at 1pm. You can access the webcast through this link:
Brødrene A&O Johansen A/S | Interim Report Q3 2023 (eventcdn.net)

For further information, please contact:                             
CEO Niels A. Johansen                                                 
CFO Per Toelstang
Brødrene A & O Johansen A/S
Rørvang 3
DK-2620 Albertslund
Denmark
Telephone: +45 70 28 00 00

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Hexagon Purus receives order to deliver hydrogen distribution systems to a leading player within the green hydrogen ecosystem3.12.2023 21:57:00 CET | Press release

(Oslo, 3 December 2023) Hexagon Purus, a world leading manufacturer of zero emission mobility and infrastructure solutions, has received purchase orders for the delivery of hydrogen distribution systems to a leading player within the green hydrogen ecosystem, worth approximately EUR 9.6 million. Hexagon Purus’ hydrogen distribution systems, including its type 4 hydrogen cylinders, will be used to deliver green hydrogen to industrial applications in Central Europe. Driving Energy Transformation “There is a growing need to move hydrogen around, and our distribution systems are significantly more cost-effective than traditional metal tube transportation solutions. We expect demand for our systems to gain further momentum as green hydrogen increasingly becomes part of the hydrogen mix”, says Michael Kleschinski, EVP Hydrogen Infrastructure & Mobility at Hexagon Purus. About the market The industrial and mobility sectors account for close to 50% of annual carbon emissions globally, and hydr

Exhibition World Bahrain Secures "World’s Leading New Exhibition and Convention Centre 2023" Award at World Travel Awards 20233.12.2023 11:00:00 CET | Press release

DUBAI, United Arab Emirates, Dec. 03, 2023 (GLOBE NEWSWIRE) -- Exhibition World Bahrain (EWB), the Middle East’s newest and largest exhibition and convention centre, is proud to announce securing the “World’s Leading New Exhibition and Convention Centre 2023” at the World Travel Awards 2023. The award accolade was presented to Dr. Nasser Qaedi, the CEO of Bahrain Tourism and Exhibitions Authority (BTEA), during the World Travel Awards 2023 Grand Final Gala Ceremony, which took place at Burj Al Arab in Dubai, UAE, on December 1, 2023, in the presence of HE Philip Joseph Pierre, the prime minister of Saint Lucia, tourism ministers, and travel elites across the globe. Exhibition World Bahrain captured the highest number of votes, clinching the internationally recognised award from Bharat Mandapam, India, and Tākina Wellington Convention and Exhibition centre, New Zealand. With this unrivalled win, the Kingdom of Bahrain has further cemented its reputation as the leading global hub for the

Merus Presents Interim Data on MCLA-129 at ESMO Asia Congress 20233.12.2023 02:40:00 CET | Press release

MCLA-129 in combination with chemotherapy in 2L+ EGFRm NSCLC planned to initiate 1Q24 UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced updated interim clinical data on MCLA-129 from ongoing expansion cohorts in non-small cell lung cancer (NSCLC) and in previously treated head and neck squamous cell carcinoma (HNSCC) were presented at the European Society for Medical Oncology (ESMO) Asia Congress 2023. “MCLA-129 is a very active drug in EGFRm NSCLC and we’re planning a focused investment to evaluate MCLA-129 in combination with chemotherapy, which we expect to start early in 2024,” said Bill Lundberg M.D., President, Chief Executive Officer of Merus. “We are in a fortunate position to have a strong balance sheet. We also recognize the importance of be

CASGEVY Gets Bahrain approval for treatment, marking it second country in the world2.12.2023 18:59:21 CET | Press release

MANAMA, Bahrain, Dec. 02, 2023 (GLOBE NEWSWIRE) -- Bahrain has become the second country in the world and the first in the Middle East to approve the use of CASGEVY (exagamglogene autotemcel) for the treatment of patients with sickle cell disease and transfusion-dependent beta-thalassemia. The treatment was developed by Vertex Pharmaceuticals and CRISPR Therapeutics, after conducting a series of successful clinical trials in the UK, US, France, Italy, and Germany, among others. Following the UK MHRA’s authorisation to use CASGEVY, Bahrain is the second country in the world and the first in the region to approve this treatment. This extraordinary development opens up new possibilities for medical advancements and reinforces Bahrain's commitment to pioneering healthcare solutions, offering a better quality of life for patients with these blood disorders. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a revolutionary gene-editing technique that holds immense potenti

Scatec at COP28: Accelerating renewable energy transition from Egypt to South Africa2.12.2023 14:01:22 CET | Press release

Dubai, 2 December 2023: This week, Scatec ASA, a leading renewable energy company, is actively engaging in the UN Climate Change Conference in Dubai (COP28). Our focus is to underscore renewable energy as an unequivocal solution to climate change and emphasise the critical need for increased green energy investments in emerging markets. COP28 serves as a pivotal platform for global stakeholders to reinforce commitments aimed at averting catastrophic consequences of climate change. Scatec aligns with climate experts in stressing the urgency of the situation and the imperative to continue advancing towards the objectives outlined in the Paris Agreement. There's no time to waste, and collective progress is crucial for safeguarding our planet's future. “We are at COP28 to highlight the key role renewable energy must play in our energy future, "At COP28, our focus is on underscoring the crucial role renewable energy must assume in shaping our energy future, particularly in emerging markets,